Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • Bitcoin CAD

    87,265.91
    +826.31 (+0.96%)
     
  • CMC Crypto 200

    1,392.76
    -3.77 (-0.27%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • RUSSELL 2000

    2,002.00
    +20.88 (+1.05%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.03
    -0.34 (-2.21%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Cymat Technologies Second Quarter 2024 Earnings: CA$0.02 loss per share (vs CA$0.025 loss in 2Q 2023)

Cymat Technologies (CVE:CYM) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CA$112.7k (down 89% from 2Q 2023).

  • Net loss: CA$1.25m (loss narrowed by 14% from 2Q 2023).

  • CA$0.02 loss per share (improved from CA$0.025 loss in 2Q 2023).

earnings-and-revenue-history
TSXV:CYM Earnings and Revenue History January 4th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cymat Technologies' share price is broadly unchanged from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 6 warning signs with Cymat Technologies (at least 4 which shouldn't be ignored), and understanding them should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.